Mian Zhou1, Weng-Lang Yang2, Youxin Ji3, Xiaoling Qiang4, Ping Wang5. 1. Center for Translational Research, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA; Hofstra North Shore-LIJ School of Medicine, Manhasset, NY 11030, USA. Electronic address: mzhou@nshs.edu. 2. Center for Translational Research, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA; Hofstra North Shore-LIJ School of Medicine, Manhasset, NY 11030, USA. Electronic address: wlyang@nshs.edu. 3. Center for Translational Research, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA; Hofstra North Shore-LIJ School of Medicine, Manhasset, NY 11030, USA. Electronic address: kevinji78@gmail.com. 4. Center for Translational Research, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA; Hofstra North Shore-LIJ School of Medicine, Manhasset, NY 11030, USA. Electronic address: xqiang@nshs.edu. 5. Center for Translational Research, The Feinstein Institute for Medical Research, Manhasset, NY 11030, USA; Hofstra North Shore-LIJ School of Medicine, Manhasset, NY 11030, USA. Electronic address: pwang@nshs.edu.
Abstract
BACKGROUND: Neuroinflammation is a key cascade after cerebral ischemia. Excessive production of proinflammatory mediators in ischemia exacerbates brain injury. Cold-inducible RNA-binding protein (CIRP) is a newly discovered proinflammatory mediator that can be released into the circulation during hemorrhage or septic shock. Here, we examine the involvement of CIRP in brain injury during ischemic stroke. METHODS: Stroke was induced by middle cerebral artery occlusion (MCAO). In vitro hypoxia was conducted in a hypoxia chamber containing 1% oxygen. CIRP and tumor necrosis factor-α (TNF-α) levels were assessed by RT-PCR and Western blot analysis. RESULTS: CIRP is elevated along with an upregulation of TNF-α expression in mouse brain after MCAO. In CIRP-deficient mice, the brain infarct volume, induction of TNF-α, and activation of microglia are markedly reduced after MCAO. Using microglial BV2 cells, we demonstrate that hypoxia induces the expression, translocation, and release of CIRP, which is associated with an increase of TNF-α levels. Addition of recombinant murine (rm) CIRP directly induces TNF-α release from BV2 cells and such induction is inhibited by neutralizing antisera to CIRP. Moreover, rmCIRP activates the NF-κB signaling pathway in BV2 cells. The conditioned medium from BV2 cells exposed to hypoxia triggers the apoptotic cascade by increasing caspase activity and decreasing Bcl-2 expression in neural SH-SY5Y cells, which is inhibited by antisera to CIRP. CONCLUSION: Extracellular CIRP is a detrimental factor in stimulating inflammation to cause neuronal damage in cerebral ischemia. GENERAL SIGNIFICANCE: Development of an anti-CIRP therapy may benefit patients with brain ischemia.
BACKGROUND: Neuroinflammation is a key cascade after cerebral ischemia. Excessive production of proinflammatory mediators in ischemia exacerbates brain injury. Cold-inducible RNA-binding protein (CIRP) is a newly discovered proinflammatory mediator that can be released into the circulation during hemorrhage or septic shock. Here, we examine the involvement of CIRP in brain injury during ischemic stroke. METHODS:Stroke was induced by middle cerebral artery occlusion (MCAO). In vitro hypoxia was conducted in a hypoxia chamber containing 1% oxygen. CIRP and tumor necrosis factor-α (TNF-α) levels were assessed by RT-PCR and Western blot analysis. RESULTS:CIRP is elevated along with an upregulation of TNF-α expression in mouse brain after MCAO. In CIRP-deficient mice, the brain infarct volume, induction of TNF-α, and activation of microglia are markedly reduced after MCAO. Using microglial BV2 cells, we demonstrate that hypoxia induces the expression, translocation, and release of CIRP, which is associated with an increase of TNF-α levels. Addition of recombinant murine (rm) CIRP directly induces TNF-α release from BV2 cells and such induction is inhibited by neutralizing antisera to CIRP. Moreover, rmCIRP activates the NF-κB signaling pathway in BV2 cells. The conditioned medium from BV2 cells exposed to hypoxia triggers the apoptotic cascade by increasing caspase activity and decreasing Bcl-2 expression in neural SH-SY5Y cells, which is inhibited by antisera to CIRP. CONCLUSION: Extracellular CIRP is a detrimental factor in stimulating inflammation to cause neuronal damage in cerebral ischemia. GENERAL SIGNIFICANCE: Development of an anti-CIRP therapy may benefit patients with brain ischemia.
Authors: Matthias Schilling; Michael Besselmann; Marcus Müller; Jan K Strecker; E Bernd Ringelstein; Reinhard Kiefer Journal: Exp Neurol Date: 2005-09-08 Impact factor: 5.330
Authors: H Nishiyama; S Danno; Y Kaneko; K Itoh; H Yokoi; M Fukumoto; H Okuno; J L Millán; T Matsuda; O Yoshida; J Fujita Journal: Am J Pathol Date: 1998-01 Impact factor: 4.307
Authors: Thomas Vogl; Klaus Tenbrock; Stephan Ludwig; Nadja Leukert; Christina Ehrhardt; Marieke A D van Zoelen; Wolfgang Nacken; Dirk Foell; Tom van der Poll; Clemens Sorg; Johannes Roth Journal: Nat Med Date: 2007-09-02 Impact factor: 53.440
Authors: Allan Tsung; Rohit Sahai; Hiroyuki Tanaka; Atsunori Nakao; Mitchell P Fink; Michael T Lotze; Huan Yang; Jianhua Li; Kevin J Tracey; David A Geller; Timothy R Billiar Journal: J Exp Med Date: 2005-03-28 Impact factor: 14.307
Authors: Adam Denes; Rishma Vidyasagar; Jianghua Feng; Johanna Narvainen; Barry W McColl; Risto A Kauppinen; Stuart M Allan Journal: J Cereb Blood Flow Metab Date: 2007-04-18 Impact factor: 6.200